Notify me when Seah H. Lim files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| EMMA | Emmaus Life Sciences, Inc. | COMMON STOCK, PAR VALUE $0.001 PER SHARE | 6.5% | $373K | 4.15M | Seah H. Lim, M.D., Ph.D. | 31 Dec 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|